Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ: INDV · Real-Time Price · USD
40.53
+0.02 (0.04%)
At close: Jul 24, 2026, 4:00 PM EDT
40.35
-0.17 (-0.43%)
Pre-market: Jul 27, 2026, 4:21 AM EDT
Indivior Pharmaceuticals Earnings Call Transcripts
Fiscal Year 2026
-
2024 results exceeded guidance, led by 20% Sublocade growth, but 2025 is forecast as a transition year with declining Suboxone Film revenue and flat Sublocade sales due to funding and competitive pressures. Cost reductions, litigation settlements, and focused R&D support long-term growth.
-
The session highlighted a strategic focus on SUBLOCADE growth, organizational simplification, and significant cost reductions, with a new operating model set for 2025-2026. Market share remains strong despite competition, and R&D is concentrated on two phase II assets, with further updates expected in early 2025.